influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.12 MG/ML [Fluzone 2026-2027]
RxNorm concept 2746474, branded drug component (sbdc).
- RxCUI
- 2746474
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2746474 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- 0.5 ML influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2026-2027] (SBD, constitutes)
- Fluzone 2026-2027 (BN, has ingredient)
- influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.12 MG/ML (SCDC, tradename of)
- influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.12 MG/ML (SCDC, tradename of)
- influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.12 MG/ML (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2746474 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2746474 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2746474. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.